{"id":213090,"name":"VAXESS TECHNOLOGIES INC.","slug":"vaxess-technologies-inc","state":"MA","country":"United States of America","description":"Life science company developing vaccines and therapeutics.","totalSpending":350000,"filings":14,"yearlySpending":[{"year":2021,"income":50000},{"year":2022,"income":120000},{"year":2023,"income":120000},{"year":2024,"income":60000}],"issues":["SCI","BUD"],"firms":["TODD STRATEGY GROUP"],"lobbyists":["DANIEL TODD","PAUL EDATTEL","JEFF LUCAS","TAYLOR SEXTON","ERIC BERGREN","KATHERINE COTTON","TED LEHMAN","NICHOLAS UEHLECKE"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","Health & Human Services, Dept of (HHS)"],"sampleDescriptions":["Issues related to the investment and commercialization of synthetic biology applications.\nAppropriations.","Issues related to the investment and commercialization of synthetic biology applications.\nAppropriations.","FY 2022 Appropriations.","Issues related to the investment and commercialization of synthetic biology applications.","General education on Vaxess.\nCOVID-19 Response."],"years":[2021,2022,2023,2024]}